Sub-Tenon’s capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation
Sign Up to like & getrecommendations! Published in 2022 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-022-05611-y
Abstract: To investigate the efficacy of sub-Tenon’s capsule triamcinolone acetonide (STTA) injections for preventing development of intraocular inflammation (IOI) related to intravitreal injection (IVI) of brolucizumab for neovascular age-related macular degeneration (nAMD). Consecutive patients with nAMD… read more here.
Keywords: brolucizumab; capsule triamcinolone; tenon capsule; injection ... See more keywords
Intraocular inflammation following intravitreal injections of anti-vascular endothelial growth factor drugs
Sign Up to like & getrecommendations! Published in 2025 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-025-06875-w
Abstract: To describe cases of infectious and non-infectious intraocular inflammation (NI-IOI) associated with intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF) drugs in the largest tertiary center with the highest number of IVI in Portugal.… read more here.
Keywords: ioi; treatment; intraocular inflammation; vascular endothelial ... See more keywords
INTRAOCULAR INFLAMMATION ASSOCIATED WITH FARICIMAB THERAPY
Sign Up to like & getrecommendations! Published in 2025 at "Retina"
DOI: 10.1097/iae.0000000000004394
Abstract: In this real-world report, faricimab was well tolerated with a low incidence of intraocular inflammation. Purpose: To report 1-year real-world evidence on intraocular inflammation (IOI) adverse events in patients undergoing faricimab therapy in a tertiary… read more here.
Keywords: ioi; intraocular inflammation; inflammation; faricimab therapy ... See more keywords
Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0259879
Abstract: Purpose To analyze the risk factors associated with emerging intraocular inflammation (IOI) after intravitreal brolucizumab injection (IVBr) to treat age-related macular degeneration (AMD). Methods This study included 93 eyes of 90 patients. The incidence of… read more here.
Keywords: age; non ioi; ioi non; ioi ... See more keywords
Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group
Sign Up to like & getrecommendations! Published in 2024 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_2973_23
Abstract: Context: Concerns about brolucizumab’s (Pagenax®) association with intraocular inflammation (IOI) limit its use despite its cost-effectiveness and efficacy. This multicentric study analyzes IOI incidence across 21 tertiary eyecare centers in India since its introduction in… read more here.
Keywords: ioi; intraocular inflammation; indian patients; brolucizumab ... See more keywords